To review and consolidate prospective therapeutic interventions for non-infectious uveitis and scleritis, focusing on those supported by human data.
Key Findings:
Non-infectious uveitis and scleritis significantly contribute to visual disability.
Current treatment options are limited and require further development.
Targeted therapies show potential to improve visual prognosis.
Interpretation:
The review highlights the need for innovative therapeutic strategies to address the limitations of existing treatments for non-infectious uveitis and scleritis.
Limitations:
Limited research on certain therapeutic approaches.
Need for more human data to support emerging treatments.
Conclusion:
Targeted therapies could transform treatment for non-infectious uveitis and scleritis, but further research is necessary to fill existing gaps.
